Your browser doesn't support javascript.
loading
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis.
Arnett, Simon; Chew, Sin Hong; Leitner, Unnah; Hor, Jyh Yung; Paul, Friedemann; Yeaman, Michael R; Levy, Michael; Weinshenker, Brian G; Banwell, Brenda L; Fujihara, Kazuo; Abboud, Hesham; Dujmovic Basuroski, Irena; Arrambide, Georgina; Neubrand, Veronika E; Quan, Chao; Melamed, Esther; Palace, Jacqueline; Sun, Jing; Asgari, Nasrin; Broadley, Simon A.
Afiliação
  • Arnett S; School of Medicine and Dentistry, Gold Coast Campus, Griffith University, Gold Coast, QLD, 4222, Australia. simon.arnett@griffithuni.edu.au.
  • Chew SH; Department of Neurology, Gold Coast University Hospital, Southport, QLD, Australia. simon.arnett@griffithuni.edu.au.
  • Leitner U; School of Medicine and Dentistry, Gold Coast Campus, Griffith University, Gold Coast, QLD, 4222, Australia.
  • Hor JY; Department of Neurology, Gold Coast University Hospital, Southport, QLD, Australia.
  • Paul F; School of Medicine and Dentistry, Gold Coast Campus, Griffith University, Gold Coast, QLD, 4222, Australia.
  • Yeaman MR; Department of Neurology, Penang General Hospital, George Town, Penang, Malaysia.
  • Levy M; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Weinshenker BG; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Banwell BL; Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, CA, USA.
  • Fujihara K; Department of Medicine, Divisions of Molecular Medicine & Infectious Diseases, Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Abboud H; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Dujmovic Basuroski I; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Arrambide G; Department of Neurology, University of Virginia, Charlottesville, VA, USA.
  • Neubrand VE; Division of Child Neurology, Children's Hospital of Philadelphia, Department of Neurology and Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Quan C; Department of Multiple Sclerosis Therapeutics, Fukushima Medical University and Multiple Sclerosis and Neuromyelitis Optica Center, Southern Tohoku Research Institute for Neuroscience, Koriyama, Japan.
  • Melamed E; Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Palace J; Department of Neurology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
  • Sun J; Neurology-Neuroimmunology Department, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Catalonia, Spain.
  • Asgari N; Department of Cell Biology, Faculty of Sciences, University of Granada, Granada, Spain.
  • Broadley SA; Department of Neurology, The National Centre for Neurological Disorders, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
J Neurol ; 2024 Jul 03.
Article em En | MEDLINE | ID: mdl-38958756
ABSTRACT

BACKGROUND:

Aquaporin-4 (AQP4) antibody-associated neuromyelitis optica spectrum disorder (NMOSD) is an antibody-mediated inflammatory disease of the central nervous system. We have undertaken a systematic review and meta-analysis to ascertain the sex ratio and mean age of onset for AQP4 antibody associated NMOSD. We have also explored factors that impact on these demographic data.

METHODS:

A systematic search of databases was conducted according to the PRISMA guidelines. Articles reporting sex distribution and age of onset for AQP4 antibody-associated NMSOD were reviewed. An initially inclusive approach involving exploration with regression meta-analysis was followed by an analysis of just AQP4 antibody positive cases.

RESULTS:

A total of 528 articles were screened to yield 89 articles covering 19,415 individuals from 88 population samples. The femalemale sex ratio was significantly influenced by the proportion of AQP4 antibody positive cases in the samples studied (p < 0.001). For AQP4 antibody-positive cases the overall estimate of the sex ratio was 8.89 (95% CI 7.78-10.15). For paediatric populations the estimate was 5.68 (95% CI 4.01-8.03) and for late-onset cases, it was 5.48 (95% CI 4.10-7.33). The mean age of onset was significantly associated with the mean life expectancy of the population sampled (p < 0.001). The mean age of onset for AQP4 antibody-positive cases in long-lived populations was 41.7 years versus 33.3 years in the remainder.

CONCLUSIONS:

The femalemale sex ratio and the mean age of onset of AQP4 antibody-associated NMOSD are significantly higher than MS. The sex ratio increases with the proportion of cases that are positive for AQP4 antibodies and the mean age of onset increases with population life expectancy.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Neurol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Neurol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália